Evidence map›Paper›PMID 33383915›Full record

ArticleInternational journal of molecular sciences2020

Spatio-Temporal Bone Remodeling after Hematopoietic Stem Cell Transplantation.

Constanze S Schwarz, Christian H Bucher, Claudia Schlundt, Sarah Mertlitz, Katarina Riesner, Martina Kalupa, Lydia Verlaat, Oskar Schmidt-Bleek, Radost A Sass, Katharina Schmidt-Bleek and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. The importance of B cells for osteogenic homeostasis.Cell communication and signaling : CCS · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Constanze S SchwarzDepartment of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Christian H BucherBerlin Institute of Health Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.ORCID 0000-0002-3900-088X
Claudia SchlundtBerlin Institute of Health Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Sarah MertlitzDepartment of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Katarina RiesnerDepartment of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Martina KalupaDepartment of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Lydia VerlaatDepartment of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Oskar Schmidt-BleekBerlin Institute of Health Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Radost A SassBerlin Institute of Health Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Katharina Schmidt-BleekBerlin Institute of Health Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.ORCID 0000-0002-5719-0867
Georg N DudaBerlin Institute of Health Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Olaf PenackDepartment of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Il-Kang NaDepartment of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin · DE

Funding

Berlin-Brandenburger Centrum für Regenerative Therapien n.a.Berliner Krebsgesellschaft n.a.Deutsche Forschungsgemeinschaft PE 1450/7-1, SCHM 2977/3-2Deutsche Krebshilfe 701135519DKMS SLS-MHG 2016 02Einstein Centrum für Regenerartive Therapien, Charité-Universitätsmedizin Berlin n.a.José Carreras Leukämie-Stiftung 11R2016, 03R\2019
6 · The paper itself

Abstract

The interaction of hematopoietic cells and the bone microenvironment to maintain bone homeostasis is increasingly appreciated. We hypothesized that the transfer of allogeneic T lymphocytes has extensive effects on bone biology and investigated trabecular and cortical bone structures, the osteoblast reconstitution, and the bone vasculature in experimental hematopoietic stem cell transplantations (HSCT). Allogeneic or syngeneic hematopoietic stem cells (HSC) and allogeneic T lymphocytes were isolated and transferred in a murine model. After 20, 40, and 60 days, bone structures were visualized using microCT and histology. Immune cells were monitored using flow cytometry and bone vessels, bone cells and immune cells were fluorescently stained and visualized. Remodeling of the bone substance, the bone vasculature and bone cell subsets were found to occur as early as day +20 after allogeneic HSCT (including allogeneic T lymphocytes) but not after syngeneic HSCT. We discovered that allogeneic HSCT (including allogeneic T lymphocytes) results in a transient increase of trabecular bone number and bone vessel density. This was paralleled by a cortical thinning as well as disruptive osteoblast lining and loss of B lymphocytes. In summary, our data demonstrate that the adoptive transfer of allogeneic HSCs and allogeneic T lymphocytes can induce profound structural and spatial changes of bone tissue homeostasis as well as bone marrow cell composition, underlining the importance of the adaptive immune system for maintaining a balanced bone biology.

Indexed as

Bone RemodelingAnimalsBiomarkersBone MarrowBone Marrow CellsDiaphysesGraft vs Host DiseaseHematopoietic Stem Cell TransplantationImmunophenotypingMiceOsteoblastsT-LymphocytesTransplantation ChimeraTransplantation, HomologousBiomarkersbone remodelinghematopoietic stem cell transplantationT lymphocytes

Identifiers

PMID33383915
PMCPMC7795370
OpenAlexW3116780111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.